• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

植入式端口通畅性:肝素与生理盐水的比较。

Implanted Port Patency: Comparing Heparin and Normal Saline.

机构信息

HonorHealth Medical Center.

出版信息

Clin J Oncol Nurs. 2021 Apr 1;25(2):169-173. doi: 10.1188/21.CJON.169-173.

DOI:10.1188/21.CJON.169-173
PMID:33739337
Abstract

BACKGROUND

To maintain implanted port patency, clinicians can better determine the difference between the use of heparin and normal saline, including risk to patients, unnecessary cost to the healthcare system, and whether heparin is effective in maintaining port patency.

OBJECTIVES

The aim is to compare the effectiveness of saline to heparin for maintaining implanted port patency and to evaluate the cost differences.

METHODS

Data were collected from 56 patients enrolled in oncology clinical trials; 37 had paired data.

FINDINGS

Results showed that saline was as effective as heparin in maintaining implanted port patency. The difference in mean cost of saline versus heparin was statistically significant. Eliminating heparin when locking implanted ports did not increase catheter occlusion rates.

摘要

背景

为了保持植入式港的通畅,临床医生可以更好地判断肝素和生理盐水的使用效果的差异,包括对患者的风险、对医疗系统的不必要成本,以及肝素是否有效地保持港的通畅。

目的

比较生理盐水和肝素在维持植入式港通畅方面的效果,并评估成本差异。

方法

从参加肿瘤临床试验的 56 名患者中收集数据;其中 37 名患者有配对数据。

发现

结果表明,生理盐水与肝素在维持植入式港通畅方面同样有效。生理盐水与肝素的平均成本差异具有统计学意义。在锁定植入港时不使用肝素不会增加导管堵塞率。

相似文献

1
Implanted Port Patency: Comparing Heparin and Normal Saline.植入式端口通畅性:肝素与生理盐水的比较。
Clin J Oncol Nurs. 2021 Apr 1;25(2):169-173. doi: 10.1188/21.CJON.169-173.
2
Efficacy of normal saline versus heparinized saline solution for locking catheters of totally implantable long-term central vascular access devices in adult cancer patients.生理盐水与肝素化生理盐水在成年癌症患者全植入式长期中央血管通路装置锁管中的疗效比较。
Cancer Nurs. 2012 Jul-Aug;35(4):E35-42. doi: 10.1097/NCC.0b013e31823312b1.
3
Heparin vs Saline Infusion to Maintain Patency of Arterial Catheters in Children: A Randomized, Double-Blind, Noninferiority Trial.肝素与生理盐水输注维持儿童动脉导管通畅的随机、双盲、非劣效性试验。
Indian Pediatr. 2024 Feb 15;61(2):132-138. Epub 2024 Jan 9.
4
Impact of decreased heparin dose for flush-lock of implanted venous access ports in pediatric oncology patients.降低肝素剂量对儿科肿瘤患者植入式静脉输液港冲洗锁定的影响。
Pediatr Blood Cancer. 2014 May;61(5):855-8. doi: 10.1002/pbc.24949. Epub 2014 Jan 24.
5
Central Line Patency: Management With Normal Saline Flushes for Adult Patients With Cancer.中心静脉置管通畅性:癌症成人患者使用生理盐水冲洗的管理。
Clin J Oncol Nurs. 2023 May 18;27(3):274-280. doi: 10.1188/23.CJON.274-280.
6
Port in oncology practice: 3-monthly locking with normal saline for catheter maintenance, a preliminary report.肿瘤学实践中的端口:每3个月用生理盐水封管以维护导管,初步报告。
J Vasc Access. 2017 Jul 14;18(4):325-327. doi: 10.5301/jva.5000740. Epub 2017 Jun 20.
7
Heparin versus 0.9% saline solution to maintain patency of totally implanted venous access ports in cancer patients: A systematic review and meta-analysis.肝素与 0.9%生理盐水在维持癌症患者完全植入式静脉输液港通畅中的比较:一项系统评价和荟萃分析。
Int J Nurs Pract. 2021 Apr;27(2):e12913. doi: 10.1111/ijn.12913. Epub 2021 Jan 22.
8
Normal saline versus heparin solution to lock totally implanted venous access devices: Results from a multicenter randomized trial.生理盐水与肝素溶液用于完全植入式静脉通路装置封管:一项多中心随机试验的结果
Eur J Oncol Nurs. 2015 Dec;19(6):638-43. doi: 10.1016/j.ejon.2015.04.001. Epub 2015 Apr 29.
9
A randomized prospective study of comparison of reservoir ports versus conventional vascular access in advanced-stage ovarian carcinoma cases treated with chemotherapy.一项关于晚期卵巢癌化疗病例中贮液囊端口与传统血管通路比较的随机前瞻性研究。
Int J Gynecol Cancer. 2005 Mar-Apr;15(2):228-32. doi: 10.1111/j.1525-1438.2005.15208.x.
10
Efficacy of normal saline solution versus heparin solution for maintaining patency of peripheral intravenous catheters in children.生理盐水溶液与肝素溶液对维持儿童外周静脉导管通畅的疗效比较。
J Emerg Nurs. 1997 Aug;23(4):306-9. doi: 10.1016/s0099-1767(97)90216-6.

引用本文的文献

1
Central venous access device terminologies, complications, and reason for removal in oncology: a scoping review.肿瘤学中中央静脉通路装置的术语、并发症和移除原因:范围综述。
BMC Cancer. 2024 Apr 19;24(1):498. doi: 10.1186/s12885-024-12099-8.
2
Evidence on port-locking with heparin versus saline in patients with cancer not receiving chemotherapy: A randomized clinical trial.未接受化疗的癌症患者中肝素与生理盐水封管的证据:一项随机临床试验。
Asia Pac J Oncol Nurs. 2022 May 21;9(9):100085. doi: 10.1016/j.apjon.2022.100085. eCollection 2022 Sep.
3
[Not Available].
[无可用内容]
Can Oncol Nurs J. 2022 Apr 1;32(2):294-302. doi: 10.5737/23688076322294302. eCollection 2022 Spring.
4
Transitioning from heparin to saline locks for central venous access devices in oncology: An evidence-based practice approach.肿瘤学中中心静脉通路装置从肝素封管转换为生理盐水封管:一种基于证据的实践方法。
Can Oncol Nurs J. 2022 Apr 1;32(2):286-293. doi: 10.5737/23688076322286293. eCollection 2022 Spring.